Pediatric Drug Formulations: A Review of Challenges and ProgressVerica Ivanovska, Aukje K. Mantel‐Teeuwisse, Carin M. A. Rademaker et al.|PEDIATRICS|2014Cited by 318
HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosisAlexius Ramcharan, Carine J.M. Doggen, Karlijn J. van Stralen et al.|Journal of Thrombosis and Haemostasis|2008Cited by 101
Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non–Vitamin K Antagonist Oral AnticoagulantsTomas Forslund, Paul Hjemdahl, Morten Andersen et al.|Stroke|2018Cited by 77